KP Tissue Q2 Revenue Grows

Second quarter sales at KP Tissue were up double-digits as an improved mix of consumer products along with strength in the away-from-home segment were key revenue drivers.

For the three month period ended June 30, total revenue was $466.3 million, an increase of 17.3% over the second quarter of 2022. Net income was $14.5 million in the quarter compared to a net loss of $35.5 million in the second quarter of the previous year.

“We are pleased that margin recovery, along with improved sales volume and a better mix in our consumer business, generated strong Adjusted EBITDA of $55.0 million in the second quarter of 2023,” said Dino Bianco, CEO of KP Tissue. “Ongoing cost management initiatives, including productivity gains and cost controls, also contributed to increasing profitability.”

For the third quarter of 2023, as commodity and other input costs begin to decline, the company will focus on maintaining its margins while also continuing to reinvest in the business to drive long-term value. Bianco said the company also anticipates a more favorable landscape as input costs trend downward. 

Additionally, KP Tissue’s TAD Sherbrooke and the Sherbrooke Expansion Project continue to ramp up production capacity to meet customer demand.